The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics
By K. Long, J. Poehlsgaard, C. Kehrenberg, S. Schwarz, B. Vester. Antimicrobial Agents and Chemotherapy, 2006
670 citations recorded by the source corpus.
Subfields: Infectious Diseases, Molecular Medicine, Small Animals
View Paper: https://www.semanticscholar.org/paper/b91d1cde71208f9406ecef03ab50454c00ef114e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Molecular Medicine
Citations in the corpus
- The RNA modification database, RNAMDB: 2011 update (2010, background): “Whereas the m 2 A chemistry shows only a small amount of antibiotic resistance (28), the m 8 A moiety confers extensive resistance to five major classes of peptidyl transferase-targeting anti-biotics (29).”
- Antibiotic resistance in Staphylococcus aureus. Current status and future prospects (2017, background): “Cfr stands for chloramphenicol and florfenicol resistance, the phenotypes with which the determinant was associated when first detected (Long et al. 2006).”
- Intrinsic and acquired resistance mechanisms in enterococcus (2012, background): “It is hypothesized that the cfr gene emerged from animal strains of bacteria that were exposed to natural compounds with an rRNA binding site similar to linezolid.(101,102) In 2011, cfr was identified in an E.”
- A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus (2011, background): “, vanA-mediated vancomycin resistance [18] and cfr-mediated linezolid resistance [19–21].”